Publications

Publications

U Toledo

  1. Erickson, H. E.; Thanvi, R.; Khan, S.; Sucheck, S. J.; Ronning, D. R. Structural and kinetic analysis of Streptomyces coelicolor GlgE isoform 1 variant V279S with glucoside-based covalent and reversible inhibitors. In preparation. [No DOI (in preparation).]

  2. Bokolo, U. C.; Dissanayake, R.; Ghosh, S.; Nada, S.; Obadawo, B. S.; Wall, K. A.; Sucheck, S. J. Synthesis of the Pentasaccharide Unit of the Pseudomonas aeruginosa Exopolysaccharide Psl Conjugation with CRM197, and Evaluation of Antigenicity in a QS-21/Pam3CSK4-Liposomal Formulation. Molecules 2025, 30 (8), 1720. DOI

  3. Kumbalathara, U. S. S.; Halicki, P. C. B.; Kalera, K.; Swarts, B. M.; Rohde, K. H.; Sucheck, S. J. Synthesis and Evaluation of Trehalose-Pks13 Inhibitor Conjugates Targeting Mycobacteria. Carbohydr. Res. 2025, 553, 109506. DOI

  4. Obadawo, B. S.; Halicki, P. C. B.; Becker, K. L.; Seeliger, J. C.; Rohde, K. H.; Sucheck, S. J. Discovery of 2,4,5-Substituted Benzoxazole Derivatives as Pks13 Inhibitors via the Scaffold Hopping Strategy. ACS Infect. Dis. 2025, 11 (6), 1460–1472. DOI

  5. Ubeysinghe, S.; Sebilleau, C.; Thotamune, W.; Rajarathna, C.; Azibere, S.; Tennakoon, M.; Payton, J.; Sprague, R.; Martin, S.; Sucheck, S.; Karunarathne, A. Recombinant-Chemosynthetic Biosensors for Probing Cell Surface Signaling of Red Blood Cells and Other Cells. Chem. Biomed. Imaging 2025, 3 (2), 95–110. DOI

  6. Sebilleau, C. O.; Sucheck, S. J. Lipopeptide Adjuvants for Antibiotics and Vaccines: The Future Step in the Fight against Multidrug-Resistant and Extensively Drug-Resistant Pathogens. Explor. Drug Sci. 2024, 2, 203–233. DOI

  7. Thanvi, R.; Nada, S.; Dissanayake, R.; Vartak, A.; Sebilleau, C. O.; Alom, N.-E.; Prestwich, E. G.; Wall, K. A.; Sucheck, S. J. Synthesis and Evaluation of a Self-Adjuvanting Pseudomonal Vaccine Based on Major Outer Membrane Porin OprF Epitopes Formulated with Low-Toxicity QS-21-Containing Liposomes. Bioconjug. Chem. 2023, 34, 893–910. DOI

  8. Johnstone, M. A.; Si, A.; Landgraf, A. D.; Sucheck, S. J.; Self, W. T. Evaluation of Derivatives of (+)-Puupehenone against Clostridioides difficile and Other Gram-Positive Bacteria. ACS Omega 2022, 7 (37), 33511–33517. DOI

  9. Thanvi, R.; Jayasinghe, T. D.; Kapil, S.; Obadawo, B. S.; Ronning, D. R.; Sucheck, S. J. Synthesis of C7/C8-Cyclitols and C7N-Aminocyclitols from Maltose and X-ray Structure of Streptomyces coelicolor GlgEI V279S in a Complex with an Amylostatin GXG-like Derivative. Front. Chem. 2022, 10, 950433. DOI

  10. Si, A.; Landgraf, A. D.; Sucheck, S. J.; Rohde, K. H. Synthesis and Evaluation of Marine Natural Product-Inspired Meroterpenoids with Selective Activity towards Dormant Mycobacterium tuberculosis. ACS Omega 2022, 7, 23487–23496. DOI

  11. Si, A.; Sucheck, S. J. Synthesis of Aminooxy Glycoside Derivatives of the Outer Core Domain of Pseudomonas aeruginosa Lipopolysaccharide. Front. Mol. Biosci. 2021, 8, 750502. DOI

  12. Khan, S. S.; Sudasinghe, T. D.; Landgraf, A. D.; Ronning, D. R.; Sucheck, S. J. Total Synthesis of Tetrahydrolipstatin, Its Derivatives, and Evaluation of Their Ability to Potentiate Multiple Antibiotic Classes against Mycobacterium Species. ACS Infect. Dis. 2021, 7, 2876–2888. DOI

  13. Si, A.; Jayasinghe, T. D.; Thanvi, R.; Ronning, D. R.; Sucheck, S. J. Stereoselective Synthesis of a 4-α-Glucoside of Valienamine and Its X-ray Structure in Complex with Streptomyces coelicolor GlgE1-V279S. Sci. Rep. 2021, 11, 13413. DOI

  14. Landgraf, A. D.; Alsegiani, A. S.; Alaqel, S.; Thanna, S.; Shah, Z. A.; Sucheck, S. J. Neuroprotective and Anti-Neuroinflammatory Properties of Ebselen Derivatives and Their Potential to Inhibit Neurodegeneration. ACS Chem. Neurosci. 2020, 11 (19), 3008–3016. DOI

  15. Hossain, M. K.; Vartak, A.; Sucheck, S. J.; Wall, K. A. Synthesis and Immunological Evaluation of a Single Molecular Construct MUC1 Vaccine Containing L-Rhamnose Repeating Units. Molecules 2020, 25 (14), 3137. DOI

  16. Thanvi, R.; Kapil, S.; Sucheck, S. J. Strategies for Developing Carbohydrates as Glycoside Hydrolase Inhibitors. In Carbohydrate Chemistry: Chemical and Biological Approaches, Volume 44; Rauter, A. P.; Lindhorst, T. K.; Queneau, Y., Eds.; Royal Society of Chemistry: Croydon, U.K., 2020; pp 207–227. DOI

  17. Nandedkar-Kulkarni, N.; Vartak, A.; Sucheck, S. J.; Wall, K. A.; Quinn, A.; Morran, M.; McInerney, M. Development of a Bioconjugate Platform for Modifying the Immune Response of Autoreactive Cytotoxic T Lymphocytes Involved in Type 1 Diabetes. Bioconjug. Chem. 2019, 30, 2049–2059. DOI

  18. Vartak, A.; Goins, C.; Nogueira de Moura, V. C.; Schreidah, C. M.; Landgraf, A. D.; Lin, B.; Du, J.; Jackson, M.; Ronning, D. R.; Sucheck, S. J. Biochemical and Microbiological Evaluation of N-Aryl Urea Derivatives against Mycobacteria and Mycobacterial Hydrolases. MedChemComm 2019, 10, 1197–1204. DOI

  19. Hossain, M. K.; Vartak, A.; Sucheck, S. J.; Wall, K. A. A Liposomal Fc Domain Conjugated to a Cancer Vaccine Enhances Both Humoral and Cellular Immunity. ACS Omega 2019, 4, 5204–5208. DOI

  20. Kapil, S.; Petit, C.; Drago, V. N.; Ronning, D. R.; Sucheck, S. J. Synthesis and In Vitro Characterization of Trehalose-Based Inhibitors of Mycobacterial Trehalose 6-Phosphate Phosphatases. ChemBioChem 2019, 20, 260–269. DOI

  21. Vartak, A.; Thanna, S.; Meyer, K.; Dermanelian, M.; Sucheck, S. J. Oligosaccharide Synthesis on Soluble High-Molecular-Weight pHEMA Using a Photo-Cleavable Linker. RSC Adv. 2018, 8, 41612–41619. DOI

  22. Hossain, M. K.; Vartak, A.; Karmakar, P.; Sucheck, S. J.; Wall, K. A. Augmenting Vaccine Immunogenicity through the Use of Natural Human Anti-Rhamnose Antibodies. ACS Chem. Biol. 2018, 13, 2130–2142. DOI

  23. Vartak, A.; Sucheck, S. J. Advances in Synthetic Approaches towards Glycoantigens. In Carbohydrate-Based Vaccines: From Concept to Clinic; Prasad, A. K., Ed.; ACS Symposium Series 1290; American Chemical Society: Washington, DC, 2018; pp 175–195. DOI

  24. Vartak, A.; Hefny, F. M.; Sucheck, S. J. Synthesis of Oligosaccharide Components of the Outer Core Domain of Pseudomonas aeruginosa Lipopolysaccharide Using a Multifunctional Hydroquinone-Derived Reducing-End Capping Group. Org. Lett. 2018, 20, 353–356. DOI

  25. Veleti, S. K.; Sucheck, S. J. Glycoconjugate-Based Inhibitors of Mycobacterium tuberculosis GlgE. In Glycoconjugate-Based Inhibitors; Witczak, Z. J.; Bielski, R., Eds.; Springer: Cham, 2018; pp 91–107. DOI

  26. Veleti, S. K.; Petit, C.; Ronning, D. R.; Sucheck, S. J. Zwitterionic Pyrrolidene-Phosphonates: Inhibitors of the Glycoside Hydrolase-Like Phosphorylase Streptomyces coelicolor GlgEI-V279S. Org. Biomol. Chem. 2017, 15, 3884–3891. DOI (Author correction: DOI).

  27. Goins, C. M.; Thanna, S.; Dajnowicz, S.; Sucheck, S. J.; Parks, J. M.; Ronning, D. R. Exploring Covalent Allosteric Inhibition of Antigen 85C from Mycobacterium tuberculosis by Ebselen Derivatives. ACS Infect. Dis. 2017, 3, 378–387. DOI

  28. Thanna, S.; Goins, C. M.; Knudson, S. E.; Slayden, R. A.; Ronning, D. R.; Sucheck, S. J. Thermal and Photoinduced Copper-Promoted C–Se Bond Formation: Synthesis of 2-Alkyl-1,2-benzisoselenazol-3(2H)-ones and Evaluation against Mycobacterium tuberculosis. J. Org. Chem. 2017, 82, 3844–3854. DOI

  29. Sucheck, S. J. Domino and Intramolecular Rearrangement Reactions as Advanced Synthetic Methods in Glycosciences. Edited by Z. J. Witczak and R. Bielski. Angew. Chem. Int. Ed. 2016, 55, 11337–11338. Book Review. DOI

  30. Thanna, S.; Knudson, S. E.; Grzegorzewicz, A.; Kapil, S.; Goins, C. M.; Ronning, D. R.; Jackson, M.; Slayden, R. A.; Sucheck, S. J. Synthesis and Evaluation of New 2-Aminothiophenes against Mycobacterium tuberculosis. Org. Biomol. Chem. 2016, 14, 6119–6133. DOI

  31. Vartak, A.; Sucheck, S. J. Recent Advances in Subunit Vaccine Carriers. Vaccines 2016, 4 (2), 12. DOI

  32. Thanna, S.; Sucheck, S. J. Targeting the Trehalose Utilization Pathways of Mycobacterium tuberculosis. MedChemComm 2016, 7 (1), 69–85. DOI

  33. Karmakar, P.; Lee, K.; Sarkar, S.; Wall, K. A.; Sucheck, S. J. Synthesis of a Liposomal MUC1 Glycopeptide-Based Immunotherapeutic and Evaluation of the Effect of L-Rhamnose Targeting on Cellular Immune Responses. Bioconjug. Chem. 2016, 27, 110–120. DOI

  34. Lindenberger, J. J.; Veleti, S. K.; Wilson, B.; Sucheck, S. J.; Ronning, D. R. Crystal Structures of Mycobacterium tuberculosis GlgE and Complexes with Noncovalent Inhibitors. Sci. Rep. 2015, 5, 12830. DOI

  35. Gaitonde, V.; Sucheck, S. J. Antitubercular Drugs Based on Carbohydrate Derivatives. In Carbohydrate Chemistry: State of the Art and Challenges for Drug Development; Cipolla, L., Ed.; Imperial College Press: London, 2015; pp 441–478. DOI

  36. Thanna, S.; Lindenberger, J. J.; Gaitonde, V.; Ronning, D. R.; Sucheck, S. J. Synthesis of 2-Deoxy-2,2-difluoro-α-maltosyl Fluoride and Its X-ray Structure in Complex with Streptomyces coelicolor GlgEI-V279S. Org. Biomol. Chem. 2015, 13, 7542–7550. DOI

  37. Veleti, S. K.; Lindenberger, J. J.; Thanna, S.; Ronning, D. R.; Sucheck, S. J. Synthesis of a Polyhydroxypyrrolidine-Based Inhibitor of Mycobacterium tuberculosis GlgE. J. Org. Chem. 2014, 79, 9444–9450. DOI

  38. Long, D. E.; Karmakar, P.; Wall, K. A.; Sucheck, S. J. Synthesis of α-L-Rhamnosyl Ceramide and Evaluation of Its Binding with Anti-Rhamnose Antibodies. Bioorg. Med. Chem. 2014, 22, 5279–5289. DOI

  39. Bouhall, S. K.; Sucheck, S. J. In Situ Preactivation Strategies for the Expeditious Synthesis of Oligosaccharides: A Review. J. Carbohydr. Chem. 2014, 33 (7–8), 347–367. DOI

  40. Gaitonde, V.; Lee, K.; Kirschbaum, K.; Sucheck, S. J. Bio-Based Bisfuran: Synthesis, Crystal Structure, and Low-Molecular-Weight Amorphous Polyester. Tetrahedron Lett. 2014, 55, 4141–4145. DOI

  41. Veleti, S. K.; Lindenberger, J. J.; Ronning, D. R.; Sucheck, S. J. Synthesis of a C-Phosphonate Mimic of Maltose-1-Phosphate and Inhibition Studies on Mycobacterium tuberculosis GlgE. Bioorg. Med. Chem. 2014, 22, 1404–1411. DOI

  42. Sarkar, S.; Salyer, A. C. D.; Wall, K. A.; Sucheck, S. J. Synthesis and Immunological Evaluation of a MUC1 Glycopeptide Incorporated into L-Rhamnose-Displaying Liposomes. Bioconjug. Chem. 2013, 24, 363–375. DOI

  43. Ibrahim, D. A.; Boucau, J.; Lajiness, D. H.; Veleti, S. K.; Trabbic, K. R.; Adams, S. S.; Ronning, D. R.; Sucheck, S. J. Design, Synthesis, and X-ray Analysis of a Glycoconjugate Bound to Mycobacterium tuberculosis Antigen 85C. Bioconjug. Chem. 2012, 23, 2403–2416. DOI

  44. Gaitonde, V.; Sucheck, S. J. Synthesis of β-Glycosyl Amides from N-Glycosyl Dinitrobenzenesulfonamides. J. Carbohydr. Chem. 2012, 31 (4–6), 353–370. DOI

  45. Karmakar, P.; Talan, R. S.; Sucheck, S. J. Mixed-Phase Synthesis of Glycopeptides Using a N-Peptidyl-2,4-dinitrobenzenesulfonamide–Thioacid Ligation Strategy. Org. Lett. 2011, 13, 5298–5301. DOI

  46. Sarkar, S.; Sucheck, S. J. Comparing the Use of 2-Methylenenaphthyl, 4-Methoxybenzyl, 3,4-Dimethoxybenzyl, and 2,4,6-Trimethoxybenzyl as N–H Protecting Groups for p-Tolyl 2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-1-thio-β-D-glucosides. Carbohydr. Res. 2011, 346, 393–400. DOI

  47. Sarkar, S.; Lombardo, S. A.; Herner, D. N.; Talan, R. S.; Wall, K. A.; Sucheck, S. J. Synthesis of a Single-Molecule L-Rhamnose-Containing Three-Component Vaccine and Evaluation of Antigenicity in the Presence of Anti-L-Rhamnose Antibodies. J. Am. Chem. Soc. 2010, 132, 17236–17246. DOI

  48. Umesiri, F. E.; Sanki, A. K.; Boucau, J.; Ronning, D. R.; Sucheck, S. J. Recent Advances towards the Inhibition of mAG and LAM Synthesis in Mycobacterium tuberculosis. Med. Res. Rev. 2010, 30, 290–326. DOI

  49. Talan, R. S.; Sanki, A. K.; Sucheck, S. J. Facile Synthesis of N-Glycosyl Amides Using a N-Glycosyl-2,4-dinitrobenzenesulfonamide and Thioacids. Carbohydr. Res. 2009, 344, 2048–2050. DOI

  50. Sanki, A. K.; Boucau, J.; Umesiri, F. E.; Ronning, D. R.; Sucheck, S. J. Design, Synthesis, and Biological Evaluation of Sugar-Derived Esters, α-Ketoesters, and α-Ketoamides as Inhibitors for Mycobacterium tuberculosis Antigen 85C. Mol. BioSyst. 2009, 5, 945–956. DOI

  51. Ragupathi, G.; Damani, P.; Srivastava, G.; Srivastava, O.; Sucheck, S. J.; Ichikawa, Y.; Livingston, P. O. Synthesis of Sialyl Lewisa (sLea, CA19-9) and Construction of an Immunogenic sLea Vaccine. Cancer Immunol. Immunother. 2009, 58, 1397–1405. DOI

  52. Sanki, A. K.; Talan, R. S.; Sucheck, S. J. Synthesis of Small Glycopeptides by Decarboxylative Condensation and Insight into the Reaction Mechanism. J. Org. Chem. 2009, 74, 1886–1896. DOI

  53. Sanki, A. K.; Boucau, J.; Ronning, D. R.; Sucheck, S. J. Antigen 85C-Mediated Acyl-Transfer between Synthetic Acyl Donors and Fragments of the Arabinan. Glycoconj. J. 2009, 26, 589–596. DOI

  54. Boucau, J.; Sanki, A. K.; Voss, B. J.; Sucheck, S. J.; Ronning, D. R. A Coupled Assay Measuring Mycobacterium tuberculosis Antigen 85C Enzymatic Activity. Anal. Biochem. 2009, 385, 120–127. DOI

  55. Sanki, A. K.; Boucau, J.; Srivastava, P.; Adams, S. S.; Ronning, D. R.; Sucheck, S. J. Synthesis of Methyl 5-S-Alkyl-5-thio-arabinofuranosides and Evaluation of Their Antimycobacterial Activity. Bioorg. Med. Chem. 2008, 16, 5672–5682. DOI

  56. Demaray, J. A.; Thuener, J. E.; Dawson, M. N.; Sucheck, S. J. Synthesis of Triazole-Oxazolidinones via a One-Pot Reaction and Evaluation of Their Antimicrobial Activity. Bioorg. Med. Chem. Lett. 2008, 18, 4868–4871. DOI

Optimer Pharmaceuticals, Inc.

  1. Liang, C.-H.; Romero, A.; Rabuka, D.; Sgarbi, P. W. M.; Marby, K. A.; Duffield, J.; Yao, S.; Cheng, M. L.; Ichikawa, Y.; Sears, P.; Hu, C.; Hwang, S.-B.; Shue, Y.-K.; Sucheck, S. J. Structure–Activity Relationships of Bivalent Aminoglycosides and Evaluation of Their Microbiological Activities. Bioorg. Med. Chem. Lett. 2005, 15, 2123–2128. DOI

  2. Romero, A.; Liang, C.-H.; Chiu, Y.-H.; Yao, S.; Duffield, J.; Sucheck, S. J.; Marby, K.; Rabuka, D.; Leung, P. Y.; Shue, Y.-K.; Ichikawa, Y.; Hwang, C.-K. An Efficient Entry to New Sugar-Modified Ketolide Antibiotics. Tetrahedron Lett. 2005, 46, 1483–1487. DOI

  3. Yao, S.; Sgarbi, P. W. M.; Marby, K. A.; Rabuka, D.; O’Hare, S. M.; Cheng, M. L.; Bairi, M.; Hu, C.; Hwang, S.-B.; Hwang, C.-K.; Ichikawa, Y.; Sears, P.; Sucheck, S. J. Glyco-Optimization of Aminoglycosides: New Aminoglycosides as Novel Anti-Infective Agents. Bioorg. Med. Chem. Lett. 2004, 14, 3733–3738. DOI

  4. Lee, L. V.; Bower, K. E.; Liang, F.-S.; Shi, J.; Wu, D.; Sucheck, S. J.; Vogt, P. K.; Wong, C.-H. Inhibition of the Proteolytic Activity of Anthrax Lethal Factor by Aminoglycosides. J. Am. Chem. Soc. 2004, 126, 4774–4775. DOI

  5. Agnelli, F.; Sucheck, S. J.; Marby, K. A.; Rabuka, D.; Yao, S.-L.; Sears, P. S.; Liang, F.-S.; Wong, C.-H. Dimeric Aminoglycosides as Antibiotics. Angew. Chem. Int. Ed. 2004, 43, 1562–1566. DOI

  6. Sucheck, S. J.; Shue, Y.-K. Combinatorial Synthesis of Aminoglycoside Libraries. Curr. Opin. Drug Discov. Dev. 2001, 4, 462–470. [No DOI identified; PubMed PMID 11727311.]

Postdoctoral

  1. Sucheck, S. J.; Wong, C.-H. RNA as a Target for Small Molecules. Curr. Opin. Chem. Biol. 2000, 4 (6), 678–686. DOI

  2. Sucheck, S. J.; Wong, A. L.; Koeller, K. M.; Boehr, D. D.; Draker, K.-A.; Sears, P.; Wright, G. D.; Wong, C.-H. Design of Bifunctional Antibiotics that Target Bacterial rRNA and Inhibit Resistance-Causing Enzymes. J. Am. Chem. Soc. 2000, 122 (21), 5230–5231. DOI

  3. Sucheck, S. J.; Greenberg, W. A.; Tolbert, T. J.; Wong, C.-H. Design of Small Molecules that Recognize RNA: Development of Aminoglycosides as Potential Antitumor Agents that Target Oncogenic RNA Sequences. Angew. Chem. Int. Ed. 2000, 39 (6), 1080–1084. DOI39:6<1080::AID data-preserve-html-node="true"-ANIE1080>3.0.CO;2-B)

Graduate

  1. Cagir, A.; Tao, Z.-F.; Sucheck, S. J.; Hecht, S. M. Solid-Phase Synthesis and Biochemical Evaluation of Conformationally Constrained Analogues of Deglycobleomycin A5. Bioorg. Med. Chem. 2003, 11 (23), 5179–5187. DOI

  2. Sucheck, S. J. Study of Naturally Occurring Nucleic Acid Interactive Agents. Dissertation/Thesis, 1998, 205 pp. [No DOI identified.]

  3. Chen, J.; Zhang, Y.-H.; Wang, L.-K.; Sucheck, S. J.; Snow, A. M.; Hecht, S. M. Inhibitors of DNA Polymerase β from Schoepfia californica. Chem. Commun. 1998, 24, 2769–2770. DOI

  4. Katono, K.; An, H.; Aoyagi, Y.; Overhand, M.; Sucheck, S. J.; Stevens, W. C., Jr.; Hess, C. D.; Zhou, X.; Hecht, S. M. Total Synthesis of Bleomycin Group Antibiotics. Total Syntheses of Bleomycin Demethyl A2, Bleomycin A2, and Decarbamoyl Bleomycin Demethyl A2. J. Am. Chem. Soc. 1998, 120 (44), 11285–11296. DOI

  5. Sucheck, S. J.; Ellena, J. F.; Hecht, S. M. Characterization of Zn(II)-Deglycobleomycin A2 and Interaction with d(CGCATGCG)2: Direct Evidence for Minor Groove Binding of the Bithiazole Moiety. J. Am. Chem. Soc. 1998, 120 (29), 7450–7460. DOI

Undergraduate

  1. Skrzypczak-Jankun, E.; Sucheck, S.; Smith, D. A. 4-Methyl-3,5-dioxopiperazineacetic Acid and 4-Methyl-3,5-dioxopiperazine-N-methylacetic Amide. Cambridge Crystallographic Data Centre deposition nos. CCDC 118966 and CCDC 118967, 1999. [No DOI (CCDC deposition).]

  2. Smith, D. A.; Sucheck, S.; Cramer, S.; Baker, D. Nitrilotriacetamide: Synthesis in Concentrated Sulfuric Acid and Stability in Water. Synth. Commun. 1995, 25 (24), 4123–4132. DOI

  3. Cramer, S.; Sucheck, S. J.; Skrzypczak-Jankun, E.; Smith, D. A. Facile Synthesis of Substituted Nitrilotriacetamides. Tetrahedron Lett. 1992, 33 (50), 7765–7768. DOI

  4. Sucheck, S. J.; Pinkerton, A. A.; Smith, D. A. Characterization of [Pb(NO3)(ntam)2]NO3, the First Metal Complex of the Neutral Tetradentate Ligand Nitrilotriacetamide (ntam). J. Chem. Soc., Chem. Commun. 1992, 367–368. DOI

Patents and Patent Applications

  1. UT Docket D2022-26; University of Central Florida Attorney Docket: 10669-389US0 Antimicrobial Compositions and Uses for Treatment of Clostridioides difficile, Mycobacterium tuberculosis, and Enterococcus faecalis Infection. Steven J. Sucheck, William T. Self. Kyle H. Rohde, Anshupriya Si, Alexander Landgraf, Sandra Geden, Michael Johnstone Filed: 5-06-2022

  2. UT Docket D2019-03 Compositions and Methods for Organic Synthesis of Polysaccharides using poly(2-hydroxyethylmethylacrylate) (pHEMA). S. J. Sucheck and A. R. Vartak Provisional Patent Appln. Filed: 7-11-2018.

  3. UT Docket D2017-06 Synthetic lipopeptide vaccines and immunotherapeutics. A. R. Vartak, S. J. Sucheck, K. A. Wall, A. Quinn, M. F. Mcinerney. International Application No.: PCT/US2017/053359; International Filing Date: 26.09.2017; Pub. No.: WO/2018/058086; Publication Date: March 29, 2018 Patent: US11007256B2, 2021-05-18

  4. UT Docket D2015-17 Substituted Isoselenazolone Anti-Infective, Anti-Inflammatory, Anti-Cancer, Cytoprotective, Neuroprotective, and Anti-Oxidant Agents. Sucheck, S. J; Thanna, S.; Ronning, D.; Landgraf, A. Provisional Patent Appln. US Serial No.: 62/352,712 Filed: 6-21-2016; PCT/US17/38467 Filed: 6-21-2017. PCT Int. Appl. (Dec 28, 2017), WO 2017223160 A1 20171228 Patent: US11053236B2, 2021-07-06

  5. UT Docket D2016-53 Anti-Infective 2-Aminothiophenes. Inventors: Sucheck, S. J; Thanna, S.; Slayden R. Provisional Patent Appln. US Serial No.: 62/325,755 Filed: 4-21-2016. PCT/US17/28782; Filed: 4-21-2017. PCT Int. Appl. (Oct 26, 2017), WO 2017184947 A1 20171026; US 2019/0119296 A1 Apr. 25, 2019. Patent: US10647725B2, 2020-05-12

  6. UT Docket D2014-20: Amorphous Polyester from Bio-Based Bis-Furan Assembly. Inventors: Giatonde, V.; Sucheck, S. J. M. Coleman Patent: US 9527952 B1. Dec 27, 2016.

  7. UT Docket D2012-01: Methods for forming peptides and peptide conjugates and peptides and peptide conjugates compositions formed thereby. Inventors: Talan, R. S.; Karmakar, P.; Sucheck, S. J. US Patent: US 8,895,869 B1 Nov 25, 2014.

  8. UT Docket D2012-14: PCT Application. Xeno-antigen-Displaying Anti-Cancer Vaccines and Method of Making. Inventors: Sucheck, S. J.; Wall, K. A.; Sarkar, S. PCT Application No. PCT/US13/026271. Filed: 2-15-2013. US 14/378,805 Filed 8-14-2014. Patent: AU 2013221448 June 8, 2017; US 10206988B2 Feb. 19, 2019.

  9. Bifunctional Antibiotics. Sucheck, S. J. and Wong, C.-H. U.S. Patent 6,921,818. Filed: 07-26-2005.

  10. Processes for the preparation of glycoconjugates of the breast cancer antigen Globo-H. O. Srivastava, O.; Srivastava, G.; Liang, C.-H; Yao, S.; Rabuka, D.; Wacowich-Scarbi, S.A.; Sucheck S. J.; Ichikawa. Y. 60/655,311. Filed: 02-22-2005.

  11. Antibacterial Agents. Liang, C.-H.; Duffield, J.; Romero, A.; Chiu, Y.-H.; Rabuka, D.; Yao, S., Sucheck, S. J.; Marby, K. A.; Shue, Y.-K.; Ichikawa, Y.; Hwang, C.-K. Patent 2013-12-26, 2013-12-26; US20130345410A1 US9200026B2, 2015-12-01

  12. New aminoglycoside antibiotics as novel anti-infective agents. Liang, C.-H.; Marby, K. A.; Rabuka, D.; Romero, A.; Sgarbi, P. W. M.; Sucheck, S. J.; Shue Y.-K; Yao S. U.S. Patent 10/606,700. Filed: 06-26-2003.